ATE509650T1 - Insulin zur verwendung in einem dosierverfahren - Google Patents

Insulin zur verwendung in einem dosierverfahren

Info

Publication number
ATE509650T1
ATE509650T1 AT03723801T AT03723801T ATE509650T1 AT E509650 T1 ATE509650 T1 AT E509650T1 AT 03723801 T AT03723801 T AT 03723801T AT 03723801 T AT03723801 T AT 03723801T AT E509650 T1 ATE509650 T1 AT E509650T1
Authority
AT
Austria
Prior art keywords
subject
glucose
insulin
processing
restored
Prior art date
Application number
AT03723801T
Other languages
English (en)
Inventor
Thomas Aoki
Original Assignee
Aoki Thomas T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aoki Thomas T filed Critical Aoki Thomas T
Application granted granted Critical
Publication of ATE509650T1 publication Critical patent/ATE509650T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/1456—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir comprising a piston rod to be moved into the reservoir, e.g. the piston rod is part of the removable reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
AT03723801T 2002-03-29 2003-03-19 Insulin zur verwendung in einem dosierverfahren ATE509650T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002094534 2002-03-29
JP2002377961A JP4177659B2 (ja) 2002-03-29 2002-12-26 インスリンを注入する装置
PCT/US2003/008781 WO2003084459A2 (en) 2002-03-29 2003-03-19 Device for infusing insulin

Publications (1)

Publication Number Publication Date
ATE509650T1 true ATE509650T1 (de) 2011-06-15

Family

ID=28793508

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03723801T ATE509650T1 (de) 2002-03-29 2003-03-19 Insulin zur verwendung in einem dosierverfahren

Country Status (8)

Country Link
EP (1) EP1494746B1 (de)
JP (1) JP4177659B2 (de)
CN (1) CN100591387C (de)
AT (1) ATE509650T1 (de)
AU (1) AU2003230711B2 (de)
CA (1) CA2480572C (de)
DK (1) DK1494746T3 (de)
WO (1) WO2003084459A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2362420T3 (es) * 2002-03-29 2011-07-05 Thomas T. Aoki Insulina para uso en un régimen de dosificación.
EP1593403A1 (de) * 2004-05-06 2005-11-09 Bionica International NV Medizinische Vorrichtung zur quantitativen und chronologischen Abfolge von Infusionsverabreichungen
JP4807774B2 (ja) 2005-10-20 2011-11-02 日東電工株式会社 液晶パネルおよび液晶表示装置
US7941200B2 (en) * 2005-12-08 2011-05-10 Roche Diagnostics Operations, Inc. System and method for determining drug administration information
CN102648992B (zh) * 2011-02-24 2013-11-20 上海微创生命科技有限公司 一种胰岛素输注控制装置
WO2012141764A2 (en) 2011-04-12 2012-10-18 Aoki Thomas T Pre-operative use of metabolic activation therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469681A (en) * 1979-07-31 1984-09-04 The Rockefeller University Method and system for the controlled release of biologically active substances to a body fluid
US4435173A (en) * 1982-03-05 1984-03-06 Delta Medical Industries Variable rate syringe pump for insulin delivery
US4498843A (en) * 1982-08-02 1985-02-12 Schneider Philip H Insulin infusion pump
WO1985002544A1 (en) * 1983-12-16 1985-06-20 Thomas Takemi Aoki Insulin delivery algorithm
US4826810A (en) 1983-12-16 1989-05-02 Aoki Thomas T System and method for treating animal body tissues to improve the dietary fuel processing capabilities thereof
US5956501A (en) * 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
US5665065A (en) * 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input
US7267665B2 (en) * 1999-06-03 2007-09-11 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US6558351B1 (en) * 1999-06-03 2003-05-06 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US6554798B1 (en) * 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
CN2402333Y (zh) * 1999-12-24 2000-10-25 王秀琪 开环式持续皮下输注胰岛素装置
US20030055380A1 (en) * 2001-09-19 2003-03-20 Flaherty J. Christopher Plunger for patient infusion device

Also Published As

Publication number Publication date
HK1068824A1 (en) 2005-05-06
EP1494746B1 (de) 2011-05-18
AU2003230711A1 (en) 2003-10-20
WO2003084459A2 (en) 2003-10-16
CA2480572C (en) 2012-02-21
JP4177659B2 (ja) 2008-11-05
CN100591387C (zh) 2010-02-24
EP1494746A4 (de) 2007-01-17
AU2003230711B2 (en) 2008-07-03
EP1494746A2 (de) 2005-01-12
CA2480572A1 (en) 2003-10-16
JP2004000461A (ja) 2004-01-08
DK1494746T3 (da) 2011-08-29
CN1655842A (zh) 2005-08-17
WO2003084459A3 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
WO2006062559A3 (en) Device for enhancing tissue glucose processing
Sandberg et al. Intra‐tooth stable isotope analysis of dentine: A step toward addressing selective mortality in the reconstruction of life history in the archaeological record
Sheridan Alterations in lipid metabolism accompanying smoltification and seawater adaptation of salmonid fish
Schätzle et al. The clinical course of chronic periodontitis: V. Predictive factors in periodontal disease
Kirschneck et al. Orthodontic forces add to nicotine-induced loss of periodontal bone: an in vivo and in vitro study
WO2005012485A3 (en) Methods for treating diabetes and related disorders using pde10a inhibitors
EP2135603A3 (de) Zusammensetzungen und Verfahren zur Erhöhung der Insulinsensitivität
DK0798971T3 (da) Forøgelse af creatin- og glycogenkoncentration i muskler
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
MXPA05007470A (es) Metodo para reducir la morbilidad y mortalidad cardiovascular en pacientes prediabeticos y pacientes con diabetes de tipo 2.
TW200514558A (en) Method of affecting sleep and sleep-related behaviors
Ritter et al. Prevalence of carious and non‐carious cervical lesions in archaeological populations from North America and Europe
ATE509650T1 (de) Insulin zur verwendung in einem dosierverfahren
Heaney The case for improving vitamin D status
BR0308229A (pt) Medicamentos contendo ingredientes ativos que diminuem o nìvel de colesterol com liberação do ingrediente ativo de tempo tardio
DE50012735D1 (de) Verwendung eines modifizierten kohlenhydrats
PT87997A (pt) Processo para a preparacao de composicoes farmaceuticas uteis para a correccao de vias metabolicas aberrantes associadas com ciclos de crescimento descontrolados de celulas tumorais e de virus contendo arn de dupla cadeia
DK1509523T3 (da) Triazaspiro-forbindelser anvendelige for at behandle eller forhindre smerte
WO2001005955A3 (en) Animals comprising human hepatocellular tissue
Chiba et al. Insulin signal decrease in muscle but not in the liver of castrated male rats from chronic exposure to fluoride
Nakahara et al. The Effect of Food Hardness on the Development of Dental Caries in Alloxan‐Induced Diabetic Rats
Sturis et al. Aspects of oscillatory insulin secretion
RU2002105274A (ru) Способ иммунореабилитации больных хроническим бронхитом
Flynn et al. Exaggerated weight loss in genetically obese (ob/ob) mice by withdrawal from morphine
ATE450267T1 (de) Verwendung von ginkgo biloba extrakten zur förderung der muskelmasse zum nachteil der fettmasse

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties